News

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...
Joincare gains exclusive rights to research, develop and commercialise BRII-693 within the Greater China region.
"The discovery was made in a West African parasite population during a study led by Dr. Abhinaya Venkatesan, a researcher at ...
During the 2019 pandemic sweeping through hospitals, an insidious companion emerged in bloodstream infections, where bacteria ...
If an intestinal inhabitant such as the bacterium Escherichia coli (E. coli) becomes resistant to many antibiotics, it can ...
Carbapenemase-producing Gram-negative organisms currently constitute a severe public health problem. Among them, the most ...
Over 660 million pilgrims gathered at the Maha Kumbh Mela in Prayagraj, India, this past February, and I'm now seeing the ...
New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in ...
As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...
Fecal microbiota transplant cut recurrent urinary tract infections by 68% in postmenopausal women and reduced ...
Tiny sensors could soon be able to "sniff" bodily fluids to diagnose bacterial infections and detect antimicrobial resistance ...
In 2023, the World Health Organization launched the Antimicrobial Resistance Diagnostic Initiative and called on researchers ...